Controlled release of soy isoflavones from multifunctional 3D printed bone tissue engineering scaffolds
- 8 July 2020
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 114, 407-420
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- NIAMS
- National Institutes of Health (R01 AR066361)
- NIH
This publication has 54 references indexed in Scilit:
- Macrophage polarization: An opportunity for improved outcomes in biomaterials and regenerative medicineBiomaterials, 2012
- Inhibition of cancer cell invasion and metastasis by genisteinCancer and Metastasis Reviews, 2010
- Current knowledge and future direction of research on soy isoflavones as a therapeutic agentsPharmacognosy Reviews, 2010
- Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffoldsJournal of The Royal Society Interface, 2009
- Bone tissue engineering: A review in bone biomimetics and drug delivery strategiesBiotechnology Progress, 2009
- Multi-targeted therapy of cancer by genisteinCancer Letters, 2008
- Epidemiology of soy exposures and breast cancer riskBritish Journal of Cancer, 2008
- Heat and pH Effects on the Conjugated Forms of Genistin and Daidzin IsoflavonesJournal of Agricultural and Food Chemistry, 2006
- Effects of Medium Perfusion Rate on Cell-Seeded Three-Dimensional Bone Constructs in VitroTissue Engineering, 2003
- Technical Note: Design of a Flow Perfusion Bioreactor System for Bone Tissue-Engineering ApplicationsTissue Engineering, 2003